Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Drug Resistance

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    August 2022
  1. JIAO Z, Yan Y, Chen Y, Wang G, et al
    Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
    PubMed     Abstract available


  2. FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
    Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    J Virol. 2022;96:e0091822.
    PubMed     Abstract available


    June 2022
  3. RICHETTA C, Subra F, Malet I, Leh H, et al
    Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
    J Virol. 2022 Jun 27:e0067622. doi: 10.1128/jvi.00676.
    PubMed     Abstract available


    March 2022
  4. JIANG L, Samant N, Liu P, Somasundaran M, et al
    Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
    J Virol. 2022;96:e0198221.
    PubMed     Abstract available


    January 2022

  5. Articles of Significant Interest In This Issue.
    J Virol. 2022;96:e0199121.
    PubMed    


  6. MURER L, Petkidis A, Vallet T, Vignuzzi M, et al
    Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    J Virol. 2022;96:e0106021.
    PubMed     Abstract available


    November 2021
  7. KHATUN M, Kumar K, Baidya A, Mondal RK, et al
    Variability in the response of HBV D-subgenotypes to antiviral therapy: designing pan D-subgenotypic reverse transcriptase inhibitors.
    J Virol. 2021 Nov 3:JVI0180021. doi: 10.1128/JVI.01800.
    PubMed     Abstract available


    September 2021
  8. LEVINE CB, Mire CE, Geisbert TW
    Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System.
    J Virol. 2021;95:e0064321.
    PubMed     Abstract available


    June 2021
  9. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    PubMed     Abstract available


    May 2021
  10. WALTER M, Perrone R, Verdin E
    Targeting conserved sequences circumvents the evolution of resistance in a viral gene drive against human cytomegalovirus.
    J Virol. 2021 May 19. pii: JVI.00802-21. doi: 10.1128/JVI.00802.
    PubMed     Abstract available


    April 2021
  11. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: